Navigation Links
Discovery demonstrates potential MS therapy could kill brain cells
Date:5/6/2011

Edmonton Researchers with the Faculty of Medicine & Dentistry at the University of Alberta have discovered that some "protective" T-cells can kill neurons. This finding is significant because a specific type of T-cell therapy is being touted in the medical community as a potential treatment for MS and other autoimmune conditions.

Dr. Fabrizio Giuliani and his post-doctoral fellow, Yohannes Haile, both from the Division of Neurology, collaborated on this research which was recently published in the Journal of Leukocyte Biology, a peer-reviewed medical journal.

"Using T-cells has been seen as a potential treatment for autoimmune diseases," says Dr. Giuliani. "But these cells that are supposed to be regulatory, when activated, they can kill. In our hands, at least, they were able to kill neurons. So this is very important. In MS literature, they were starting to talk about using the infusion of these cells as treatment. This area needs to be studied more before these cells are used as a therapy for MS patients."

The finding was serendipitous, says Giuliani.

"We were using some of the cells that we have described here as a control in our project. And then the T-cells did something interesting, something we weren't expecting. In fact, we were expecting the exact opposite response with these cells.

"We were looking at how a specific type of T-cell could prevent neuronal death and then we found out they were doing the killingThese are the best findings when you are expecting something different and then you observe an amazing phenomenon."

T-cells are very important their primary role is to attack foreign viruses or bacteria and to regulate or maintain immune system tolerance. However, when T-cell tolerance is disrupted, they can cause autoimmune diseases.

Researchers in the medical community have thought if they could carefully collect regulatory T-cells and inject them into patients with autoimmune diseases, these T-cells could keep autoimmune diseases under control. Work with lab models that had MS and were treated with T-cells was promising. However, recent studies of human cells have shown humans have different subpopulations of T-cells some of which do not have a regulatory function.

Giuliani and Haile worked with different subpopulations of T-cells and discovered some were toxic to neurons. Giuliani and his colleague are the first medical researchers to demonstrate that activating a specific type of T-cell can kill brain cells.

They want to continue their work in this area to determine what causes some T-cells to behave this way.

"We want to take the research further. We want to continue this story in an attempt to try and solve the mystery."


'/>"/>

Contact: Raquel Maurier
raquel.maurier@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Related biology news :

1. Worm discovery could help 1 billion people worldwide
2. New discovery could green up hundreds of everyday products
3. Discovery identifies elaborate G-protein network in plants
4. A chance discovery may revolutionize hydrogen production
5. A world first: The discovery of a common genetic cause of autism and epilepsy
6. Discovery of protein that alters nutrition of breast cancer cells
7. Missouri Botanical Garden makes rare discovery of plant genus
8. Discovery of a biochemical basis for broccolis cancer-fighting ability
9. Discovery of source of glycogen manufacturing errors sheds light on fatal disease
10. MU researchers believe discovery could lead to testing that displaces colonoscopies
11. Discovery of blood proteins that are red flags for ectopic pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)... -- Perkotek an innovation leader in attendance control systems is proud to announce the introduction ... to make sure the right employees are actually signing in, and to even control ... ... ... ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
Breaking Biology Technology: